### Evidence Statement CG15AdultES132
A medium-sized randomised controlled study found that the addition of metformin to an insulin regimen provided by CSII was able to reduce the total IR required by the person with Ty pe 1 diabetes (including reduced basal therapy) as compared to placebo over a period of six months. This was achieved without significant change to HbA 1c or increased incidence of hy poglycaemia


